cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.13656106.v1
title: Nanoencapsulation of unsaturated omega-3 fatty acids as protection against oxidation: A systematic review and data-mining

description: The chemical structure of unsaturated fatty acids makes them highly prone to oxidation, which decreases their nutritional properties. Nanocarriers have the ability to protect unstable nutraceuticals and take them to their specific targets. Thus, the aim is to determine the effectiveness of nanoencapsulation of omega-3 unsaturated fatty acids as protection against oxidation, as well as to apply data-mining approach to identify nanoencapsulation profiles. Three databases were used to search for studies focused on comparing omega-3 encapsulation to the active compound in its raw form. Studies without oxidation test or no use omega 3-rich oil as active ingredient in nanoformulations were excluded. Twenty-three studies were included in the systematic review. The qualitative analysis indicated that the main evaluated parameters were encapsulation efficiency (%), physical-chemical parameters and oxidation (analyzed at different storage temperatures), oil type, and whether the formulation was added to food. With regard to quantitative analysis, studies that did not perform oxidation tests focused on comparing free oil to the encapsulated one were excluded. Data-mining indicated that encapsulation efficiency and particle size were the main characteristic defining nanocarrier’s effectiveness in protecting the oil against oxidation. Nevertheless, it is important to note the main characteristics associated with oil protection in nanocarriers.
DOI: 10.6084/m9.figshare.14102309.v1
title: Effects of resistance training combined with a ketogenic diet on body composition: a systematic review and meta-analysis

description: We evaluated the effects of ketogenic diets (KDs) on body mass (BM), fat mass (FM), fat-free mass (FFM), body mass index (BMI), and body fat percentage (BFP) compared to non-KDs in individuals performing resistance training (RT). Online electronic databases including PubMed, the Cochrane Library, Web of Science, Embase, SCOPUS, and Ovid were searched to identify initial studies until February 2021. Data were pooled using both fixed and random-effects methods and were expressed as weighted mean difference (WMD) and 95% confidence intervals (CI). Out of 1372 studies, 13 randomized controlled trials (RCTs) that enrolled 244 volunteers were included. The pooled results demonstrated that KDs significantly decreased BM [(WMD = −3.67 kg; 95% CI: −4.44, −2.90, <i>p</i> &lt; 0.001)], FM [(WMD = −2.21 kg; 95% CI: −3.09, −1.34, <i>p</i> &lt; 0.001)], FFM [(WMD = −1.26 kg; 95% CI: −1.82, −0.70, <i>p</i> &lt; 0.001)], BMI [(WMD = −1.37 kg.m<sup>−2</sup>; 95% CI: −2.14, −0.59, <i>p</i> = 0.022)], and BFP [(WMD = −2.27%; 95% CI: −3.63, −0.90, <i>p</i> = 0.001)] compared to non-KDs. We observed beneficial effects of KDs compared to non-KDs on BM and body fat (both FM and BFP) in individuals performing RT. However, adherence to KDs may have a negative effect on FFM, which is not ameliorated by the addition of RT.
DOI: 10.6084/m9.figshare.14102309
title: Effects of resistance training combined with a ketogenic diet on body composition: a systematic review and meta-analysis

description: We evaluated the effects of ketogenic diets (KDs) on body mass (BM), fat mass (FM), fat-free mass (FFM), body mass index (BMI), and body fat percentage (BFP) compared to non-KDs in individuals performing resistance training (RT). Online electronic databases including PubMed, the Cochrane Library, Web of Science, Embase, SCOPUS, and Ovid were searched to identify initial studies until February 2021. Data were pooled using both fixed and random-effects methods and were expressed as weighted mean difference (WMD) and 95% confidence intervals (CI). Out of 1372 studies, 13 randomized controlled trials (RCTs) that enrolled 244 volunteers were included. The pooled results demonstrated that KDs significantly decreased BM [(WMD = −3.67 kg; 95% CI: −4.44, −2.90, <i>p</i> &lt; 0.001)], FM [(WMD = −2.21 kg; 95% CI: −3.09, −1.34, <i>p</i> &lt; 0.001)], FFM [(WMD = −1.26 kg; 95% CI: −1.82, −0.70, <i>p</i> &lt; 0.001)], BMI [(WMD = −1.37 kg.m<sup>−2</sup>; 95% CI: −2.14, −0.59, <i>p</i> = 0.022)], and BFP [(WMD = −2.27%; 95% CI: −3.63, −0.90, <i>p</i> = 0.001)] compared to non-KDs. We observed beneficial effects of KDs compared to non-KDs on BM and body fat (both FM and BFP) in individuals performing RT. However, adherence to KDs may have a negative effect on FFM, which is not ameliorated by the addition of RT.
DOI: 10.17197/sumfolkdb_v01_02
title: Summariska folkmängdsdatabasen, version 1.2

description: Den summariska folkmängdsdatabasen innehåller en sammanställning av de summariska folkmängdsredogörelser för åren 1895-1930 som gjordes av Gunnar Myrdals forskargrupp under 1930-talet. De bygger på information som skickades in till Statistiska centralbyrån (SCB) från landets präster. Det finns information om migration, folkmängd och antalet födda och döda på församlingsnivå. Myrdals forskargrupp excerperade viss information från originalblanketter, på egna excerperingsformulär. Det är dessa excerpter som har inregistrerats av DDB och som finns tillgängliga via sökverktyget för den summariska folkmängdsdatabasen.
DOI: 10.20351/29he20200109
title: POWELL-2020 Cruise, RV Hespérides

description: Oceanographic data acquired during the POWELL-2020 Cruise (29HE20200109) on board the Research Vessel Hespérides in 2020.
DOI: 10.20351/29gd20200623
title: RADMED-3 Cruise, RV García del Cid

description: Oceanographic data acquired during the RADMED-3 Cruise (29GD20200623) on board the Research Vessel García del Cid in 2020.
DOI: 10.20351/29sg20200214
title: ABRIC-1 Cruise, RV Sarmiento de Gamboa 

description: Oceanographic data acquired during the ABRIC-1 Cruise (29SG20200214) on board the Research Vessel Sarmiento de Gamboa in 2020.
DOI: 10.20351/29he20200207
title: BRAVOSEIS-3 Cruise, RV Hespérides

description: Oceanographic data acquired during the BRAVOSEIS-3 Cruise (29HE20200207) on board the Research Vessel Hespérides in 2020.
DOI: 10.20351/29sg20200201
title: RESNEP-2_LEG2 Cruise, RV Sarmiento de Gamboa 

description: Oceanographic data acquired during the RESNEP-2_LEG2 Cruise (29SG20200201) on board the Research Vessel Sarmiento de Gamboa in 2020.
DOI: 10.20351/29gd20000620
title: ARPA Cruise, RV García del Cid

description: Oceanographic data acquired during the ARPA Cruise (29GD20000620) on board the Research Vessel García del Cid in 2000.
DOI: 10.20351/29he20100802
title: ZEE-2010-GAROE Cruise, RV Hespérides

description: ZEE-2010-GAROE Cruise (29HE20100802) carried out on the Research Vessel Hespérides in 2010.
DOI: 10.6084/m9.figshare.19535566
title: An Eye Tracking Study from Women with Body Weight Dissatisfaction

description: The response latency results were pre-processed, trial with errors were removed (0.82% of data), we also removed trials with response latencies of more or less than 3 SD (0.45% of data). Accuracy of all participants more than 90%, there was no further analysis. Eye tracking results were pre-processed, participants whose fixation point is less than 80% in the area of interest were excluded
DOI: 10.6084/m9.figshare.19535566.v1
title: An Eye Tracking Study from Women with Body Weight Dissatisfaction

description: The response latency results were pre-processed, trial with errors were removed (0.82% of data), we also removed trials with response latencies of more or less than 3 SD (0.45% of data). Accuracy of all participants more than 90%, there was no further analysis. Eye tracking results were pre-processed, participants whose fixation point is less than 80% in the area of interest were excluded
DOI: 10.20351/29gd20200220
title: UNIBARNA-2020 Cruise, RV García del Cid 

description: Oceanographic data acquired during the UNIBARNA-2020 Cruise (29SG20200220) on board the Research Vessel García del Cid in 2020.
DOI: 10.20351/29sg20200710
title: iFADO-RADPROF Cruise, RV Sarmiento de Gamboa 

description: Oceanographic data acquired during the iFADO-RADPROF Cruise (29SG20200710) on board the Research Vessel Sarmiento de Gamboa in 2020.
DOI: 10.20351/29gd20200302
title: RECOMARES Cruise, RV García del Cid 

description: Oceanographic data acquired during the RECOMARES Cruise (29GD20200302) on board the Research Vessel García del Cid in 2020.
DOI: 10.6084/m9.figshare.20517645
title: Oxygen uptake by wrack- and driftwood acclimated p. platensis

description: Supplmental information for the publication OXYGEN UPTAKE BY WRACK- AND DRIFTWOOD-ACCLIMATED POPULATIONS OF PLATORCHESTIA PLATENSIS DURING FEEDING AND FASTING
DOI: 10.6084/m9.figshare.20517645.v2
title: Oxygen uptake by wrack- and driftwood acclimated p. platensis

description: Supplmental information for the publication OXYGEN UPTAKE BY WRACK- AND DRIFTWOOD-ACCLIMATED POPULATIONS OF PLATORCHESTIA PLATENSIS DURING FEEDING AND FASTING
DOI: 10.6084/m9.figshare.20517645.v1
title: Oxygen uptake by wrack- and driftwood acclimated p. platensis

description: Supplmental information for the publication OXYGEN UPTAKE BY WRACK- AND DRIFTWOOD-ACCLIMATED POPULATIONS OF PLATORCHESTIA PLATENSIS DURING FEEDING AND FASTING
DOI: 10.20351/29sg20200903
title: CRIMA Cruise, RV Sarmiento de Gamboa 

description: Oceanographic data acquired during the MERS Cruise (29SG20200903) on board the Research Vessel Sarmiento de Gamboa in 2020.
DOI: 10.20351/29sg20200821
title: INTEMARES-A22B-0820 Cruise, RV Sarmiento de Gamboa 

description: Oceanographic data acquired during the INTEMARES-A22B-0820 Cruise (29SG20200821) on board the Research Vessel Sarmiento de Gamboa in 2020.
DOI: 10.6084/m9.figshare.14248485
title: Longitudinal association of dietary carbohydrate and the risk cardiovascular disease: a dose-response meta-analysis

description: Previous findings on the association of dietary carbohydrate with cardiovascular disease (CVD) events and mortality are inconsistent. We aimed to assess the relationship between dietary carbohydrate and the incidence of cardiovascular events and mortality. A comprehensive literature search of MEDLINE (PubMed), Scopus, ISI Web of Science, and EMBASE, was performed up to June 2019. Prospective cohort studies which examined dietary carbohydrate in relation to fatal and non-fatal myocardial infarction, fatal and non-fatal stroke, heart failure, and sudden cardiac death were included in our study. Summary HRs and 95% CIs were estimated using a random-effects model. A total of 19 cohort studies including 15,663,111 participants were identified. Combining 27 effect sizes with 1,577,225 CVD cases led to a significant association between dietary carbohydrate and total CVD events (HR= 1.05, 95% CI: 1.00, 1.10; I<sup>2</sup> = 38.5%), but no association was observed between dietary carbohydrate and CVD mortality (HR = 1.02; 95% CI: 0.91, 1.14; I<sup>2</sup>=27.1%, derived from 8 effect sizes with 106,412 events), and CHD events (HR = 1.03, 95% CI: 0.98, 1.09; I<sup>2</sup> = 46.6%, derived from 18 effect sizes with 1,549,281 events). Moreover, using 8 effect sizes with 6,829 cases, higher carbohydrate intake was associated with increased risk of stroke (HR = 1.13; 95% CI: 1.01, 1.27; I<sup>2</sup>= 0.0%). In subgroup analysis by sex, higher carbohydrate intake increased the risk of total CVD events (HR: 1.10; 95% CI: 1.03, 1.17; I<sup>2</sup> = 0.0%), and CHD (HR: 1.10; 95% CI: 1.01, 1.20; I<sup>2</sup>= 15.0%), but not stroke and CVD mortality in women. No significant association was found in men. Low- to very-low-certainty evidence suggests that higher carbohydrate intake is directly but slightly associated with CVD and stroke risk, while no association was found for CHD and CVD mortality. We also found sex-specific associations.
DOI: 10.6084/m9.figshare.14248485.v1
title: Longitudinal association of dietary carbohydrate and the risk cardiovascular disease: a dose-response meta-analysis

description: Previous findings on the association of dietary carbohydrate with cardiovascular disease (CVD) events and mortality are inconsistent. We aimed to assess the relationship between dietary carbohydrate and the incidence of cardiovascular events and mortality. A comprehensive literature search of MEDLINE (PubMed), Scopus, ISI Web of Science, and EMBASE, was performed up to June 2019. Prospective cohort studies which examined dietary carbohydrate in relation to fatal and non-fatal myocardial infarction, fatal and non-fatal stroke, heart failure, and sudden cardiac death were included in our study. Summary HRs and 95% CIs were estimated using a random-effects model. A total of 19 cohort studies including 15,663,111 participants were identified. Combining 27 effect sizes with 1,577,225 CVD cases led to a significant association between dietary carbohydrate and total CVD events (HR= 1.05, 95% CI: 1.00, 1.10; I<sup>2</sup> = 38.5%), but no association was observed between dietary carbohydrate and CVD mortality (HR = 1.02; 95% CI: 0.91, 1.14; I<sup>2</sup>=27.1%, derived from 8 effect sizes with 106,412 events), and CHD events (HR = 1.03, 95% CI: 0.98, 1.09; I<sup>2</sup> = 46.6%, derived from 18 effect sizes with 1,549,281 events). Moreover, using 8 effect sizes with 6,829 cases, higher carbohydrate intake was associated with increased risk of stroke (HR = 1.13; 95% CI: 1.01, 1.27; I<sup>2</sup>= 0.0%). In subgroup analysis by sex, higher carbohydrate intake increased the risk of total CVD events (HR: 1.10; 95% CI: 1.03, 1.17; I<sup>2</sup> = 0.0%), and CHD (HR: 1.10; 95% CI: 1.01, 1.20; I<sup>2</sup>= 15.0%), but not stroke and CVD mortality in women. No significant association was found in men. Low- to very-low-certainty evidence suggests that higher carbohydrate intake is directly but slightly associated with CVD and stroke risk, while no association was found for CHD and CVD mortality. We also found sex-specific associations.
DOI: 10.6084/m9.figshare.14308597
title: Effects of betaine supplementation on cardiovascular markers: A systematic review and Meta-analysis

description: Controversy regarding the effects of betaine supplementation on cardiovascular markers has persisted for decades. This systematic review and meta-analysis compared the effects of betaine supplementation on cardiovascular disease (CVD) markers. Studies examining betaine supplementation on CVD markers published up to February 2021 were identified through PubMed, the Cochrane Library, Web of Science, Embase, and SCOPUS. Betaine supplementation had a significant effect on concentrations of betaine (MD: 82.14 μmol/L, 95% CI: 67.09 to 97.20), total cholesterol (TC) (MD: 14.12 mg/dl, 95% CI%: 9.23 to 19.02), low-density lipoprotein (LDL) (MD: 10.26 mg/dl, 95% CI: 6.14 to 14.38)], homocysteine (WMD: −1.30 micromol/L, 95% CI: −1.61 to −0.98), dimethylglycine (DMG) (MD: 21.33 micromol/L, 95% CI: 13.87 to 28.80), and methionine (MD: 2.06 micromol/L, 95% CI: 0.23 to 3.88). Moreover, our analysis indicated that betaine supplementation did not affect serum concentrations of triglyceride (TG), high-density lipoprotein (HDL), fasting blood glucose (FBG), C-reactive protein (CRP), liver enzymes [alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT)], and blood pressure. Our subgroup analysis suggested that a maximum dose of 4 g/d might have homocysteine-lowering effects without any adverse effect on lipid profiles reported with doses of ≥4 g/d. In conclusion, the present systematic review and meta-analysis supports the advantage of a lower dose of betaine supplementation (&lt;4 g/d) on homocysteine concentrations without the lipid-augmenting effect observed with a higher dosage.
DOI: 10.6084/m9.figshare.14308597.v1
title: Effects of betaine supplementation on cardiovascular markers: A systematic review and Meta-analysis

description: Controversy regarding the effects of betaine supplementation on cardiovascular markers has persisted for decades. This systematic review and meta-analysis compared the effects of betaine supplementation on cardiovascular disease (CVD) markers. Studies examining betaine supplementation on CVD markers published up to February 2021 were identified through PubMed, the Cochrane Library, Web of Science, Embase, and SCOPUS. Betaine supplementation had a significant effect on concentrations of betaine (MD: 82.14 μmol/L, 95% CI: 67.09 to 97.20), total cholesterol (TC) (MD: 14.12 mg/dl, 95% CI%: 9.23 to 19.02), low-density lipoprotein (LDL) (MD: 10.26 mg/dl, 95% CI: 6.14 to 14.38)], homocysteine (WMD: −1.30 micromol/L, 95% CI: −1.61 to −0.98), dimethylglycine (DMG) (MD: 21.33 micromol/L, 95% CI: 13.87 to 28.80), and methionine (MD: 2.06 micromol/L, 95% CI: 0.23 to 3.88). Moreover, our analysis indicated that betaine supplementation did not affect serum concentrations of triglyceride (TG), high-density lipoprotein (HDL), fasting blood glucose (FBG), C-reactive protein (CRP), liver enzymes [alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT)], and blood pressure. Our subgroup analysis suggested that a maximum dose of 4 g/d might have homocysteine-lowering effects without any adverse effect on lipid profiles reported with doses of ≥4 g/d. In conclusion, the present systematic review and meta-analysis supports the advantage of a lower dose of betaine supplementation (&lt;4 g/d) on homocysteine concentrations without the lipid-augmenting effect observed with a higher dosage.
DOI: 10.6084/m9.figshare.14191517
title: A priori dietary patterns and cardiovascular disease incidence in adult population-based studies: a review of recent evidence

description: Cardiovascular disease (CVD) is the leading cause of death worldwide. Studies using the <i>a priori</i> dietary pattern approach have been criticized for the heterogeneity of their scoring methods. This review aimed to evaluate the evidence on the association between <i>a priori</i> dietary patterns and CVD incidence in recent adult population-based studies. Similar to the conclusions of previous systematic reviews and meta-analyses, our review found that the majority of recent studies suggested that Mediterranean diet (6 out of 10 studies), Dietary Approaches to Stop Hypertension diet (4 out of 6 studies), Dietary Guidelines-based (11 out of 13 studies) patterns, and other emerging dietary patterns, including carbohydrate quality, Dietary Inflammatory Index, Plant-based Diet Index and Healthy Nordic Food Index, were cardioprotective in the general population; however, there was substantial heterogeneity among the studies, possibly due to differences in scoring methods and analytical approaches used and inclusion of different confounders, as well as other methodological drawbacks, such as low numbers of cases and short follow-up periods. Future studies should simultaneously examine and compare multiple <i>a priori</i> dietary patterns in a specific population using a uniform statistical approach. A consensus on the scoring methods for each <i>a priori</i> dietary pattern is also necessary.
DOI: 10.6084/m9.figshare.14191517.v1
title: A priori dietary patterns and cardiovascular disease incidence in adult population-based studies: a review of recent evidence

description: Cardiovascular disease (CVD) is the leading cause of death worldwide. Studies using the <i>a priori</i> dietary pattern approach have been criticized for the heterogeneity of their scoring methods. This review aimed to evaluate the evidence on the association between <i>a priori</i> dietary patterns and CVD incidence in recent adult population-based studies. Similar to the conclusions of previous systematic reviews and meta-analyses, our review found that the majority of recent studies suggested that Mediterranean diet (6 out of 10 studies), Dietary Approaches to Stop Hypertension diet (4 out of 6 studies), Dietary Guidelines-based (11 out of 13 studies) patterns, and other emerging dietary patterns, including carbohydrate quality, Dietary Inflammatory Index, Plant-based Diet Index and Healthy Nordic Food Index, were cardioprotective in the general population; however, there was substantial heterogeneity among the studies, possibly due to differences in scoring methods and analytical approaches used and inclusion of different confounders, as well as other methodological drawbacks, such as low numbers of cases and short follow-up periods. Future studies should simultaneously examine and compare multiple <i>a priori</i> dietary patterns in a specific population using a uniform statistical approach. A consensus on the scoring methods for each <i>a priori</i> dietary pattern is also necessary.
DOI: 10.20351/29sg20200808
title: INTEMARES-A22MU-0820 Cruise, RV Sarmiento de Gamboa 

description: Oceanographic data acquired during the INTEMARES-A22MU-0820 Cruise (29SG20200808) on board the Research Vessel Sarmiento de Gamboa in 2020.
DOI: 10.6084/m9.figshare.14191460
title: The impact of rice bran oil consumption on the serum lipid profile in adults: a systematic review and meta-analysis of randomized controlled trials

description: Dyslipidemia/hyperlipidemia is recognized among the risk factors for lifestyle related diseases. A healthy diet, rich in vegetable oils such as rice bran oil (RBO), may aid to improve serum lipid levels. Thus, the aim of this study was to assess the effects of rice bran oil (RBO) consumption on serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c) and triglyceride (TG) levels in adults. The following online databases were searched for manuscripts published until October 7<sup>th</sup> 2020: PubMed/Medline, Scopus, Clarivate Analytics’ Web of Science, Cochrane Central Register of Controlled Trials, and Google Scholar. The effect sizes were expressed as weighted mean difference (WMD) with 95% confidence intervals (CI). A total of 8 eligible trials with 14 effect sizes were included in this meta-analysis. Our analysis revealed that the consumption of RBO significantly decreased serum TC (WMD: −7.29 mg/dL, 95% CI: −11.32, −3.25, P = 0.000), LDL-c (WMD: −7.62 mg/dL, 95% CI: −11.10, −4.14, P = 0.000) and TG (WMD: −9.19 mg/dL, 95% CI: −17.99, −0.38, P = 0.041) levels. So, available evidence suggests that RBO consumption can significantly decrease serum TC, LDL-c and TG levels. Hence, it may play a role in reducing dyslipidemia/hyperlipidemia risk.
DOI: 10.6084/m9.figshare.14191460.v1
title: The impact of rice bran oil consumption on the serum lipid profile in adults: a systematic review and meta-analysis of randomized controlled trials

description: Dyslipidemia/hyperlipidemia is recognized among the risk factors for lifestyle related diseases. A healthy diet, rich in vegetable oils such as rice bran oil (RBO), may aid to improve serum lipid levels. Thus, the aim of this study was to assess the effects of rice bran oil (RBO) consumption on serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c) and triglyceride (TG) levels in adults. The following online databases were searched for manuscripts published until October 7<sup>th</sup> 2020: PubMed/Medline, Scopus, Clarivate Analytics’ Web of Science, Cochrane Central Register of Controlled Trials, and Google Scholar. The effect sizes were expressed as weighted mean difference (WMD) with 95% confidence intervals (CI). A total of 8 eligible trials with 14 effect sizes were included in this meta-analysis. Our analysis revealed that the consumption of RBO significantly decreased serum TC (WMD: −7.29 mg/dL, 95% CI: −11.32, −3.25, P = 0.000), LDL-c (WMD: −7.62 mg/dL, 95% CI: −11.10, −4.14, P = 0.000) and TG (WMD: −9.19 mg/dL, 95% CI: −17.99, −0.38, P = 0.041) levels. So, available evidence suggests that RBO consumption can significantly decrease serum TC, LDL-c and TG levels. Hence, it may play a role in reducing dyslipidemia/hyperlipidemia risk.